A GI-MAP is a stool test that uses PCR to detect the DNA of specific organisms living in your gut, alongside a set of markers describing how the gut itself is working. It is useful when symptoms have persisted without explanation and standard testing has come back unremarkable. It is not a diagnosis, it is not a substitute for a conventional workup when warning signs are present, and some of what it reports is far better validated than the rest. Knowing which part is which is what makes the test worth running.

What it measures

The panel covers four broad categories:

Pathogens with an established role in disease, including organisms such as C. difficile, Salmonella, Campylobacter, Giardia, Cryptosporidium and Entamoeba histolytica
H. pylori, and separately its virulence factor genes, which is a genuinely useful distinction, because the strain matters when weighing whether to treat
Commensal and opportunistic organisms, the normal residents plus bacteria, yeasts and parasites that can overgrow
Intestinal health markers describing inflammation, digestion, absorption and immune activity in the gut

The markers that carry the most weight

Not every number on the report is equally meaningful. A few are well established in mainstream gastroenterology and deserve the most attention:

Calprotectin is the strongest of them. It is a protein released by neutrophils in inflamed bowel, and it reliably separates inflammatory bowel disease from irritable bowel syndrome. A 2023 systematic review and meta-analysis confirms its diagnostic performance in exactly that distinction, and its particular strength is its negative predictive value: a low result is meaningful reassurance that active inflammatory bowel disease is unlikely. A raised result is a reason to escalate to gastroenterology, not to reach for a supplement protocol.

Pancreatic elastase-1 reflects how much digestive enzyme your pancreas is producing. Low values point toward exocrine pancreatic insufficiency, which is a real and treatable diagnosis frequently missed in people carrying a label of “IBS” for years.

Steatocrit indicates fat malabsorption. Occult blood requires follow-up on its own terms. Secretory IgA describes gut immune activity, and anti-gliadin IgA is a marker of immune reactivity to gluten, though neither diagnoses celiac disease. Celiac requires its own specific testing, done while you are still eating gluten.

What it cannot tell you

This is the part most articles about this test leave out.

It is a laboratory-developed test, run in a certified laboratory but not FDA approved or cleared, and the reference ranges for many organisms are not the product of the same evidence base as a standard clinical assay.
It does not diagnose SIBO. Small intestinal bacterial overgrowth is assessed with a breath test, because a stool sample describes the far end of the digestive tract, not the small intestine.
“Dysbiosis” is a description, not a diagnosis. Microbiome science is genuinely early. Seeing an organism above or below a reference range does not establish that it is causing your symptoms, and treating every out-of-range line item is how people end up on twelve supplements and no better.
It does not replace a colonoscopy. No stool panel does.

When conventional workup comes first

Some symptoms mean the next step is a gastroenterologist, not a functional stool panel. Please do not run a test and wait if you have:

Blood in the stool, or black tarry stools
Unintentional weight loss
Iron-deficiency anemia
New, persistent change in bowel habit over the age of about 45 to 50
A family history of colorectal cancer or inflammatory bowel disease
Symptoms that wake you from sleep
Fever, or difficulty swallowing

None of these rule out also running the panel later. They simply come first, because the cost of a delayed diagnosis here is high.

Who it genuinely helps

Where the test earns its place is with people whose symptoms are real and persistent, whose standard evaluation was unremarkable, and who are left with “you have IBS, try eating more fiber.” Bloating that will not resolve, unpredictable stools, reflux, skin flares, fatigue that tracks with meals, or symptoms that began after a course of antibiotics or a bout of food poisoning abroad. In those cases the panel can identify a treatable infection, a pancreatic enzyme deficiency, or genuine inflammation that changes the plan entirely.

It is also reasonable when a hormone or weight picture is not adding up, since digestion and absorption underpin both.

What we do with the result

A result is only worth having if something happens because of it. In practice that means treating what is genuinely treatable, addressing digestion and absorption before adding a long supplement list, retesting when there is a specific question to answer rather than out of routine, and referring on when the findings point outside our scope.

That is what gut health and functional medicine means here: a full-hour first consult, testing chosen for a reason, and an honest account of what each result does and does not prove.

If fatigue and weight are also part of the picture, GLP-1, tirzepatide and retatrutide covers the metabolic side, and hormones have their own starting points for men and women.

Consults are available in person at our Deerfield Beach clinic and by telehealth anywhere in Florida.

Medically reviewed by Krishna Borges, MSN, APRN, FNP-C. This article is for general education and is not a substitute for individual medical advice.